Índice do Artigo
Conteúdo do Artigo
How to defend channel intelligence ROI without falling into the dashboard trap
· 3 min read

How to defend channel intelligence ROI without falling into the dashboard trap

Defending data ROI in the pharmacy channel requires showing the cost of deciding late on stockouts, rather than justifying the tool through reporting time savings.


Bringing a new layer of intelligence to the sales management board usually runs into a legitimate demand: leadership wants to see concrete examples of financial return before approving any stack investment.

Sales managers and trade leaders need solid economic justifications. The mistake is not in demanding ROI, but in the premise of where that return is sought. Frequently, an attempt is made to justify a data tool by calculating how many hours the analyst will save building spreadsheets or how many extra reports the team can generate per month. Operational time savings matter, but they do not convince the finance committee to open up budget.

Real value does not lie in the speed of compiling past data, but in the speed of fixing what is broken at the point of sale before the sale disappears.

The invisible cost of stockout delay

To understand the true economic impact, it is necessary to separate two concepts that are usually treated as equivalent: providing inventory visibility and acting on critical absence.

Having a dashboard that displays the consolidated inventory of a pharmacy chain merely attests to the past. When the sales team discovers, weeks later through traditional reports, that a priority SKU has vanished from the shelves in a strategic region, the loss has already happened. The patient does not wait for normalized replenishment; they migrate to an alternative brand. Revenue is not merely delayed; it is permanently transferred to the competitor.

The sell-out loss mechanism is fueled by the interval between the moment a stockout occurs and the moment the team receives a clear signal to act. If the field spends days cross-referencing files to figure out where the product is missing, the negotiation opportunity evaporates.

Where intelligence moves the needle

A specialized intelligence layer for the pharmaceutical channel does not replace field execution nor does it promise to solve all retail variables at once. The role of a solution like Dinn Stock, currently available on the market, is to map where there is absence, stockout, stockout risk, or replenishment opportunity, delivering a prioritized list of points of sale, chains, and SKUs that require immediate intervention.

When sales leadership manages to direct negotiation and visit efforts precisely to the units where revenue is draining due to a lack of product, the conversation with the finance board changes shape. The focus stops being the cost of a software license and becomes the revenue recovered by eliminating operational blindness.

The question the internal committee should ask when evaluating investments in channel data is not how much time the team saves on extraction, but how much revenue the company stops burning by arriving late at the point of sale.

Transform data into strategic decisions

Dinn centralizes market intelligence for the pharmaceutical industry — real-time POS monitoring, out-of-stock tracking, and sell-out data.

Request a demo
Back to Blog